Substituted piperazine compounds and their use as fatty acid oxidation inhibitors

Details for Australian Patent Application No. 2003300827 (hide)

International Classifications

Event Publications

27 May 2004 Complete Application Filed

Priority application(s): 60/431,506 05.12.02 US

5 August 2004 Application Open to Public Inspection

Published as AU-B-2003300827

13 August 2009 Application Accepted

Published as AU-B-2003300827

15 October 2009 Alteration of Name

The name of the applicant has been altered to Gilead Palo Alto, Inc.

10 December 2009 Standard Patent Sealed

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.